The Tether™ - Vertebral Body Tethering System Post Approval Study

February 21, 2024 updated by: ZimVie
This study is an opportunity to provide continued reasonable assurance of the safety and probable benefit of The Tether HUD. The study will collect long term safety and efficacy information from patients who have had their idiopathic scoliosis treated via anterior vertebral body tethering (AVBT) with The Tether.

Study Overview

Status

Recruiting

Detailed Description

While spinal fusion remains the standard surgical treatment for progressive idiopathic scoliosis, concerns about the long-term effects of spinal fusion have led to the investigation of growth-modulation techniques. Anterior Vertebral Body Tethering (AVBT) is one such technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spine begins to remodel according to the Hueter-Volkmann Law, bone growth is relatively inhibited in areas of increased pressure (convex or tethered side) and relatively stimulated in areas of decreased pressure or tension (concave side). Following this principle, AVBT has been shown to alter spinal growth with the potential to correct scoliosis while maintaining spine flexibility.

The objective of the study is to assess the ongoing safety and probable benefit of The Tether HUD which was approved by the FDA under an HDE. Subject enrollment and data collection will be managed by the Harms Study Group (HSG) and Setting Scoliosis Straight Foundation (SSSF) Registry. Institutions that are HSG members or affiliates, with Investigators/surgeons that are trained and approved to perform surgeries with The Tether, will participate in the registry. Ten sites from this group will be identified as study sites specific to this Tether post-approval study (PAS). Consecutive subjects from these sites, that meet the eligibility criteria of this study, will be flagged in the registry as the PAS cohort and the study endpoints will be assessed across this population.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • San Diego, California, United States, 92123
        • Recruiting
        • Rady Children's Hospital
        • Contact:
          • Peter O Newton, MD
          • Phone Number: 858-966-6789
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • Children's Hospital Colorado
        • Contact:
          • Mark Erickson, MD
    • Florida
      • Jacksonville, Florida, United States, 32207
        • Active, not recruiting
        • Nemours Children's Health
    • Georgia
      • Atlanta, Georgia, United States, 30342
        • Recruiting
        • Children's Healthcare of Atlanta
        • Contact:
          • Joshua Murphy, MD
    • Louisiana
      • New Orleans, Louisiana, United States, 70121
        • Recruiting
        • Ochsner Health
        • Contact:
          • Lawrence Haber, MD
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Recruiting
        • Mayo Clinic
        • Contact:
    • Missouri
      • Columbia, Missouri, United States, 65201
        • Recruiting
        • University of Missouri - Columbia
        • Contact:
          • Daniel Hoernschemeyer, MD
          • Phone Number: 573-882-2663
    • New York
      • New York, New York, United States, 10029
        • Recruiting
        • Mount Sinai
        • Contact:
          • Baron Lonner, MD
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19140
        • Recruiting
        • Shriners Children's Hopital
        • Contact:
          • Amer F Samdani
    • Washington
      • Seattle, Washington, United States, 98105
        • Recruiting
        • Seattle Children's
        • Contact:
          • Burt Yaszay, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The Tether™ - Vertebral Body Tethering System is indicated for skeletally immature patients that require surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis, with a major Cobb angle of 30 to 65 degrees whose osseous structure is dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging. Patients should have failed bracing and/or be intolerant to brace wear.

Description

Inclusion Criteria:

  • Diagnosis of progressive idiopathic scoliosis
  • Skeletally immature, based on both Risser (<5) and Sanders (<8) assessments
  • Major Cobb angle ≥30° and ≤65°
  • Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging
  • Failed or intolerant to bracing

Exclusion Criteria:

  • Presence of any systemic infection, local infection, or skin compromise at the surgical site
  • Prior spinal surgery at the level(s) to be treated
  • Documented poor bone quality, defined as a T-score -1.5 or less
  • Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions
  • Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent
  • Unwillingness to sign Informed Consent Form and participate in study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Tether
Patients who have received The Tether HUD for treatment of idiopathic scoliosis.
Anterior Vertebral Body Tethering (AVBT) is a technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spine begins to remodel according to the Hueter-Volkmann Law, bone growth is relatively inhibited in areas of increased pressure (convex or tethered side) and relatively stimulated in areas of decreased pressure or tension (concave side).
Other Names:
  • AVBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of SAEs and device- &/or procedure-related AEs
Time Frame: AVBT surgery to five year post-op
The primary safety endpoint is the rate of Serious Adverse Events (SAEs) and device- and/or procedure-related Adverse Events (AEs)
AVBT surgery to five year post-op
Percentage of subjects with maintenance of the major Cobb angle less than or equal to 40 degrees at 60 months post-surgery
Time Frame: AVBT surgery to five year post-op
The primary probable benefit endpoint is the percentage of patients with maintenance of the major Cobb angle less than or equal to 40 degrees at 60 months post-surgery
AVBT surgery to five year post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Events
Time Frame: AVBT surgery to five year post-op
Rates of overall Adverse Events; relatedness, severity, time to event
AVBT surgery to five year post-op
Reoperation
Time Frame: AVBT surgery to five year post-op
Rates and types of reoperation
AVBT surgery to five year post-op
Number of participants with new curves that develop above or below the tethered portion of the spine.
Time Frame: AVBT surgery to five year post-op
Determined by radiographic assessment, defined as a new curve development with Cobb angle measurement greater than or equal to 40 degrees.
AVBT surgery to five year post-op
Number of participants with secondary curves that progress to the point of clinical significance.
Time Frame: AVBT surgery to five year post-op
Determined by radiographic assessment, typically defined as an increase in secondary Cobb angle measurement greater than or equal to 10 degrees, or medical intervention/ intent to treat.
AVBT surgery to five year post-op
Number of participants with device integrity failures including cord breakage and screw migration.
Time Frame: AVBT surgery to five year post-op
AVBT surgery to five year post-op
Mean (SD) and distributions of sagittal balance (mm) from pre-op through last visit
Time Frame: Baseline to five year post-op
Sagittal balance is assessed on the lateral radiograph by measuring the difference (i.e. distance) between posterosuperior aspect of the S1 vertebral body and the plumb line.
Baseline to five year post-op
Mean (SD) and distributions of lumbar lordosis (degrees) from pre-op through last visit.
Time Frame: Baseline to five year post-op
Lumbar lordosis is defined as the angle at the intersection of lines perpendicular to lines parallel to the superior endplate of T12 and the superior endplate of S1.
Baseline to five year post-op
Mean score of Scoliosis Research Society 22r Patient Questionnaire
Time Frame: Baseline to five year post-op
Self-reported outcomes of function, pain, self-image, mental health, and satisfaction. Mean score; 5 (Best) - 1 (Worst)
Baseline to five year post-op
Number of participants with compromised lung function
Time Frame: Baseline to five year post-op
Comparison of the measured lung function (forced expiratory volume (FEV1), forced vital capacity (FVC) and FEV1/FVC) to predicted values, lower and upper limits of normal to determine if lung function is within the limits of the normal population.
Baseline to five year post-op
Measurement (degrees rotation) of trunk shape by scoliometer device. Mean (SD) [min, max] will be reported.
Time Frame: Baseline to five year post-op
Measurements of trunk shape or rib hump will be collected preoperatively and at each follow-up visit. A standard scoliometer device will be used to measure the rib hump in the thoracic and/or lumbar regions of the spine, as applicable. The scoliometer is laid across the curve at right angles with the 0° mark at the spinous process and resting gently on the skin, not pressed down. The degrees of rotation are read and recorded.
Baseline to five year post-op
Trunk flexibility as determined by distance (cm) of flexion and lateral bend using fingertip to floor method.
Time Frame: Baseline to five year post-op
Baseline to five year post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2020

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

July 20, 2020

First Submitted That Met QC Criteria

August 5, 2020

First Posted (Actual)

August 10, 2020

Study Record Updates

Last Update Posted (Estimated)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 21, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RAU2019-40S

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scoliosis Idiopathic

Clinical Trials on Anterior Vertebral Body Tethering

3
Subscribe